Glow Lifetech Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Roberto Paolo Carducci
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 65 International Boulevard Toronto ON Canada M9W 6L9
- IPO Date
- Oct 28, 2021
- Website
- glowlifetech.com
- Similar Companies
- Business
- Glow Lifetech Corp. (CSE: GLOW; OTCQB: GLWLF; FSE: 9DO) is a Canadian biotechnology company focused on developing and commercializing high-performance, water-soluble natural ingredients for nutraceutical, cannabinoid, and botanical applications using its proprietary, plant-based MyCell delivery system technology; the MyCell platform, a CPhI award-winning, pharma-grade solution employing 100% natural food-grade components, enhances bioavailability, absorption, onset speed, taste profile, and dosing predictability of active compounds such as vitamins, cannabinoids including THC and CBG, curcumin, vitamin K, iron, and other botanicals, transforming fat-soluble substances into water-compatible concentrates with near-100% bioavailability. The company offers core products encompassing water-soluble ingredients in liquid format; customized multi-ingredient blends for targeted health benefits; market-ready, fully-finished consumer products including precision-dosed capsules and oils; and in-house brands such as MOD for cannabinoid drops and oils and .decimal for nutraceutical offerings, with exclusive North American rights to micellization technology for specified cannabis, hemp-derived ingredients, and nutrients; Glow serves functional foods, beverages, supplements, and personal care sectors through asset-light, factor-in-factory manufacturing partnerships emphasizing scalability, cost efficiency, and rapid market entry, primarily targeting cannabis retailers, health brands, and natural product innovators in the $800 billion global natural health market. Founded in 2019 as a subsidiary of Scryb Inc. (formerly Relay Medical Corp.) and publicly listed via reverse takeover in March 2021, Glow Lifetech maintains corporate headquarters at 65 International Blvd., Suite 206, Toronto, Ontario, Canada M9W 6L9, with operations centered in Canada including expansions into Ontario (over 1,000 stores), Saskatchewan, New Brunswick, and national distribution growth. Recent developments include achieving debt-free status in November 2025 by eliminating all outstanding debt over 18 months to bolster financial flexibility; reporting record Q3 2025 financial results with 193% year-over-year revenue growth, sustained high gross margins, and first positive cash flow from operations in September 2025; securing retail listings for MOD products in over 60 One Plant Corp. stores across Ontario and Saskatchewan in October 2025 and 100+ FIKA Company stores in Ontario in August 2025; launching into Saskatchewan with 10 product listings and completing first shipments in September 2025; commissioning a new automated bottling line in July 2025 tripling MOD production capacity alongside a CBG:THC drops launch; expanding Ontario distribution to 850+ stores with 30% growth from Q4 2024 and achieving #2 oil brand ranking by June 2025; completing final payments under its Swiss PharmaCan AG share exchange for MyCell technology in December 2024; reducing warrant overhang by 20+ million through exercises yielding $450,000+ proceeds in October 2025; and delivering 196% Q2 2025 revenue growth with improved cash flow in August 2025, positioning the company for sustained profitability and national scaling.
Glow Lifetech Achieves Warrant-Free Capital Structure Following Elimination of 70 Million Warrants and 20% Reduction in Fully Diluted Shares
Glow Lifetech Reports Record Q1 2026 Results; 35% YoY Revenue Growth, 27% Sequential Growth and Continued National Expansion Momentum
Glow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth Strategy
Glow Lifetech Reports Fourth Quarter and Full Year 2025 Financial Results; 146% YoY Revenue Growth and Second Consecutive Quarter of Positive Cash Flow
Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired
Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy
Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical
Glow Lifetech Reports Record Q3 2025 Financial Results; 193% YoY Revenue Growth and Achieves First Positive Cash Flow from Operations
Glow Lifetech Achieves Debt-Free Status, Strengthening Balance Sheet and Enhancing Financial Flexibility for Growth
Glow Lifetech Reduces Warrant Overhang by 20+ Million as Largest Shareholder Exercises $450k+ At-the-Money Warrants, Bolstering Balance Sheet
Nova Capital Trading Announces Filing of Early Warning Report Related to Exercise of Warrants in the Capital of Glow Lifetech
Glow Lifetech Provides Commercial & Corporate Update; Launches New Key Accounts, Advances National Expansion
Glow Lifetech to Present at the Annual Smallcap Discoveries Conference in Vancouver
Glow Lifetech Expands MOD and .decimal brands in Saskatchewan Market, Advancing National Growth Strategy
Glow Lifetech Reports 196% YoY Revenue Growth and Improved Cash Flow in Q2 2025, Sets Stage for Continued Momentum in H2
Glow Expands Ontario Distribution with MOD Launch in 100+ FIKA Company Stores, One of Canada's Largest Cannabis Retailers
Glow Lifetech Provides Commercial Update; Expands to 1000+ Stores in Ontario and Achieves #2 Oil Brand with MOD
Glow Lifetech Grants Stock Options
Glow Lifetech Reports 238% YoY Revenue Growth and Near-Breakeven EBITDA in Q1 2025, Marking Third Straight Quarter of 40%+ Sequential Revenue Growth
Glow Lifetech Reports 2024 Financials, Delivering Record Q4 Results with 46% Quarterly Revenue Growth and Strengthened Balance Sheet